Nexalin Technology, Inc. (Nasdaq:NXL)
Health Care/Life Sciences • Medical Equipment/Supplies
CIK 1527352
Company
Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices helps people with mental health illness. The company was founded by John Patrick Claude on October 19, 2010 and is headquartered in Houston, TX.
Address
1776 Yorktown
Suite 550
Houston, Texas 77056
1776 Yorktown
Suite 550
Houston, Texas 77056
Employees
6
6
Stock Info
Close
$2.4300
$2.4300
Day Range
2.3700 - 2.4900
2.3700 - 2.4900
52 Week Range
0.3522 - 4.4899
0.3522 - 4.4899
Average volume
403.07K
403.07K
Short Interest
355.87K (02/14/25)
355.87K (02/14/25)
% of Float Shorted
3.30%
3.30%
Market Cap
$32.33M
$32.33M
Revenue
$110.75K
$110.75K
Net Income
-$4.65M
-$4.65M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Director & Chief Medical Officer David Owens |
Chairman Leslie Bernhard |
Independent Director Alan Kazden |
Independent Director Ben V. Hu |
SEC filings
Date | Form | Event |
---|---|---|
20 Dec, 2024 | S-1 | |
8 Nov, 2024 | 10-Q | |
1 Nov, 2024 | 8-K | |
30 Oct, 2024 | 4 | |
2 Oct, 2024 | 4 | |
2 Oct, 2024 | 4/A | |
2 Oct, 2024 | 4 | |
25 Sep, 2024 | 4/A | |
25 Sep, 2024 | 8-K | |
25 Sep, 2024 | 4 | |
19 Sep, 2024 | 8-K | |
3 Sep, 2024 | 8-K | |
15 Aug, 2024 | 4 | |
8 Aug, 2024 | 10-Q | |
30 Jul, 2024 | 8-K | |
29 Jul, 2024 | DEF 14A | |
16 Jul, 2024 | 8-K | |
3 Jul, 2024 | 8-K | |
1 Jul, 2024 | 424B4 | |
1 Jul, 2024 | 4 | |
28 Jun, 2024 | 8-K | |
27 Jun, 2024 | EFFECT | |
26 Jun, 2024 | CORRESP | |
26 Jun, 2024 | CORRESP | |
26 Jun, 2024 | S-1/A | |
24 Jun, 2024 | S-1/A | |
24 Jun, 2024 | CORRESP | |
21 Jun, 2024 | 4 | |
21 Jun, 2024 | UPLOAD | |
18 Jun, 2024 | 8-K | |
14 Jun, 2024 | S-1/A | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | CORRESP | |
5 Jun, 2024 | UPLOAD | |
23 May, 2024 | S-1 | |
21 May, 2024 | 8-K | |
14 May, 2024 | RW | |
10 May, 2024 | 10-Q | |
26 Apr, 2024 | 8-K | |
16 Apr, 2024 | S-3 | |
11 Apr, 2024 | 8-K | |
27 Mar, 2024 | 10-K | |
20 Mar, 2024 | 8-K | |
17 Jan, 2024 | DEF 14A | |
13 Nov, 2023 | 8-K | |
13 Nov, 2023 | 10-Q | |
6 Oct, 2023 | DEF 14A | |
5 Oct, 2023 | 4 | |
5 Oct, 2023 | 4 | |
5 Oct, 2023 | 4 | |
5 Oct, 2023 | 4 | |
28 Sep, 2023 | 8-K | |
10 Aug, 2023 | 10-Q | |
30 Jun, 2023 | 4/A | |
30 Jun, 2023 | 4/A | |
30 Jun, 2023 | 3/A | |
30 Jun, 2023 | 3/A | |
30 Jun, 2023 | 4/A | |
2 Jun, 2023 | 8-K | |
16 May, 2023 | 8-K | |
10 May, 2023 | 10-Q | |
27 Mar, 2023 | 10-K | |
10 Nov, 2022 | 10-Q | |
3 Oct, 2022 | 8-K | |
29 Sep, 2022 | 4 | |
22 Sep, 2022 | 4/A | |
20 Sep, 2022 | 4 | |
20 Sep, 2022 | 4 | |
20 Sep, 2022 | 4 | |
20 Sep, 2022 | 8-K/A | |
20 Sep, 2022 | 8-K | |
20 Sep, 2022 | 4 | |
20 Sep, 2022 | 4 | |
19 Sep, 2022 | 3 | |
19 Sep, 2022 | 424B4 | IPO completed |
19 Sep, 2022 | 3 | |
19 Sep, 2022 | 3 | |
19 Sep, 2022 | 3 | |
19 Sep, 2022 | 3 | |
19 Sep, 2022 | 3 | |
16 Sep, 2022 | 8-K | |
16 Sep, 2022 | CERT | |
15 Sep, 2022 | 8-A12B | |
15 Sep, 2022 | S-1/A | |
15 Sep, 2022 | S-1/A | |
15 Sep, 2022 | EFFECT | |
12 Sep, 2022 | CORRESP | |
12 Sep, 2022 | CORRESP | |
24 Aug, 2022 | S-1/A | |
31 May, 2022 | S-1/A | |
31 May, 2022 | CORRESP | |
16 May, 2022 | S-1/A | |
16 May, 2022 | CORRESP | |
6 May, 2022 | UPLOAD | |
28 Apr, 2022 | S-1/A | |
27 Apr, 2022 | CORRESP | |
22 Apr, 2022 | UPLOAD | |
8 Apr, 2022 | S-1/A | |
8 Apr, 2022 | CORRESP | |
9 Feb, 2022 | UPLOAD | |
4 Feb, 2022 | S-1/A | |
31 Jan, 2022 | S-1/A | |
19 Jan, 2022 | UPLOAD | |
4 Jan, 2022 | S-1 | |
21 Dec, 2021 | UPLOAD | |
8 Dec, 2021 | DRS/A | |
19 Nov, 2021 | UPLOAD | |
2 Nov, 2021 | DRS/A | |
15 Oct, 2021 | UPLOAD | |
17 Sep, 2021 | DRS |
Last update:2025-03-06 12:43:30.747990
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.